Weight loss key for Type 2 diabetics to achieve remission: NHG Health trial

CNAAbout 4 min readAug 27, 2025Watch original
THE SUMMARYAI-generated

Key Concepts:

  • Type 2 Diabetes Remission
  • Weight Loss as a Key Factor
  • National Healthcare Group (NHG) Program
  • Low-Calorie Meal Replacement
  • 5% Body Weight Loss Threshold
  • Dietary and Cultural Adaptation
  • Blood Sugar Management vs. Weight Management

Main Findings of the NHG Program:

The National Healthcare Group's (NHG) one-year clinical trial demonstrated that weight loss is a crucial factor in achieving remission for individuals with type 2 diabetes. The study revealed that over two in five patients (more than 40%) successfully reversed their condition without relying on medication or surgery. This highlights the potential for lifestyle interventions, specifically weight management, to significantly impact diabetes outcomes.

Patient Experience: Wendy Faulk

Miss Wendy Faulk, diagnosed with type 2 diabetes two years prior, participated in the trial to avoid lifelong medication. The program involved an initial phase of replacing meals with low-calorie liquid meal replacements, followed by a gradual reintroduction of solid foods and increased physical activity. Faulk initially found the transition to liquid meals challenging, expressing fear of the change from solid food. However, she adapted within two weeks. Over 18 months, she lost over 10 kg and adopted healthier habits, including cycling to work, improved sleep, and reduced junk food consumption.

Weight Loss and Remission Probability:

The study found a strong correlation between weight loss and the likelihood of achieving remission. Patients who lost over 5% of their body weight were more than five times more likely to achieve remission compared to those who did not. This 5% threshold serves as a significant target for weight loss interventions in managing type 2 diabetes.

Shift in Treatment Focus:

Traditionally, type 2 diabetes management has primarily focused on controlling blood sugar levels. However, this study emphasizes the importance of targeting weight loss, particularly in obese patients with early-stage diabetes. Weight management can significantly improve the chances of achieving a non-diabetic state, suggesting a paradigm shift in treatment strategies.

Pilot Program at Polyclinics:

The NHG program is currently undergoing a pilot phase at Amokio and Hogan Polyclinics. Dieticians play a crucial role in monitoring patients' adherence to the diet plan, tracking weight, blood sugar levels, and blood pressure. Regular follow-up appointments, approximately once a month, ensure personalized support and guidance.

Adaptation from UK Study:

The program is modeled after a UK study but has been adapted to suit Singapore's specific dietary habits and cultural context. This adaptation is crucial for ensuring the program's effectiveness and sustainability within the local population.

Projected Increase in Diabetes Cases:

The number of people living with diabetes in Singapore is projected to rise to 1 million by the year 2050. This alarming projection underscores the urgent need for effective prevention and management strategies, such as the NHG program, to mitigate the impact of the diabetes epidemic.

Notable Quote:

  • "Traditionally, when we manage patients with uh type 2 diabetes, we tend to focus on the sugars, the blood sugars. And what this study shows us is that actually if we target the weight uh loss that actually in patients who are obese and with early diabetes, this actually can significantly improve their chances of actually going into a non-diabetic state." - This quote highlights the shift in focus from blood sugar management to weight management for diabetes remission.

Technical Terms:

  • Type 2 Diabetes Remission: A state where a person with type 2 diabetes no longer needs medication to maintain healthy blood sugar levels.
  • Low-Calorie Meal Replacement: Liquid or powdered products designed to replace regular meals while providing a controlled number of calories.

Conclusion:

The NHG's clinical trial provides compelling evidence that weight loss is a key factor in achieving remission for type 2 diabetes. The program's success, demonstrated by the high remission rate among patients who lost over 5% of their body weight, highlights the potential of lifestyle interventions in managing the condition. The shift in focus from blood sugar control to weight management, along with the program's adaptation to Singapore's dietary and cultural context, offers a promising approach to combatting the rising prevalence of diabetes.

AI summaries can miss context or contain errors. Check important details against the original video.

MAKE IT YOURS

Read. Remember. Reuse.

Free tools

Go a little deeper.

Have a question about this video? Load its transcript to open the video chat.